Mild to moderate proteinuria is a heralding sign for acute kidney injury and mortality for intensive care unit patients

Creative Commons License

Yeter H. H., Yıldırım T., Eyüpoğlu D., Paşayev T., Aslan A., Çetik S., ...Daha Fazla

Turkish Journal of Medical Sciences, cilt.49, sa.2, ss.543-550, 2019 (SCI-Expanded) identifier identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 49 Sayı: 2
  • Basım Tarihi: 2019
  • Doi Numarası: 10.3906/sag-1802-183
  • Dergi Adı: Turkish Journal of Medical Sciences
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.543-550
  • Anahtar Kelimeler: 28-day mortality, Acute kidney injury, Proteinuria, Urine dipstick protein
  • Hacettepe Üniversitesi Adresli: Evet

Özet

Background/aim: Lack of early predictors of acute kidney injury is currently delaying timely diagnosis. This study was done to evaluate the relationship between mild to moderate proteinuria and incidence of acute kidney injury (AKI) and 28-day mortality in intensive care unit (ICU) patients. Material and methods: This observational, retrospective study was conducted in the internal medicine ICU. A total of 796 patients were screened and 525 patients were used for this analysis. Proteinuria was measured by urine dipstick test. AKI was defined according to the Kidney Disease: Improving Global Outcomes (KDIGO) guidelines. Results: Patients with dipstick urine protein positivity on admission had higher proportion of AKI and 28-day mortality compared to dipstick urine protein negative group [164 (59.6%) vs. 111 (44.4%) and 101 (36.7%) vs. 54 (21.6%), P = 0.01 and P < 0.01, respectively]. Urine dipstick protein positivity was also a significant predictor of 28-day mortality in patients with GFR > 60 mL/min (hazard ratio: 1.988, 95% confidence interval 1.380–2.862). Conclusion: Proteinuria before ICU admission is a risk factor for development of AKI within seven days of ICU stay and also is a risk factor for 28-day mortality, even in patients with GFR > 60 mL/min.